Exosomes

Kimera Labs stands at the forefront of exosome biotechnology, specializing in the production of perinatal mesenchymal stem cell (MSC)-derived exosome products tailored for both cosmetic treatments and research applications. The clinic operates within rigorous FDA guidelines, ensuring that its offerings meet the highest standards of pharmaceutical quality and safety. With a commitment to innovation, Kimera Labs is recognized as a semifinalist in the prestigious $101 million XPRIZE Healthspan competition, highlighting its significant contributions to the fields of healthy aging and regenerative medicine. The facility is dedicated to advancing the understanding and application of MSC-derived exosomes through extensive research and development initiatives. Its team of experts is committed to providing healthcare providers with cutting-edge clinical solutions, leveraging the latest scientific findings to enhance therapeutic and diagnostic practices. By offering premium quality exosomes with optimal purity, Kimera Labs not only facilitates clinical breakthroughs but also serves as a pioneering force in exosome research and education. Those interested in exploring the innovative biotechnology products available at Kimera Labs are encouraged to schedule a lab tour to gain deeper insights into its groundbreaking processes and the transformative benefits of MSC-derived exosomes.